It could also contribute to degradation of insulin, reduced degradation of apolipoprotein B, and increased hepatic glucose production, leading to hyperinsulinemia, hypertriglyceridemia and eventually DM[22, 23]. The gene discussed is APOB; the disease is hypertriglyceridemia.